JP2014521605A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014521605A5 JP2014521605A5 JP2014521610A JP2014521610A JP2014521605A5 JP 2014521605 A5 JP2014521605 A5 JP 2014521605A5 JP 2014521610 A JP2014521610 A JP 2014521610A JP 2014521610 A JP2014521610 A JP 2014521610A JP 2014521605 A5 JP2014521605 A5 JP 2014521605A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- item
- als3p
- candida
- vaccine according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161510896P | 2011-07-22 | 2011-07-22 | |
| US61/510,896 | 2011-07-22 | ||
| PCT/US2012/000328 WO2013015831A1 (en) | 2011-07-22 | 2012-07-20 | Methods and compositions for vaccinating against staphylococcus aureus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014521605A JP2014521605A (ja) | 2014-08-28 |
| JP2014521605A5 true JP2014521605A5 (enExample) | 2015-08-27 |
Family
ID=47601425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014521610A Pending JP2014521605A (ja) | 2011-07-22 | 2012-07-20 | Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓに対してワクチン接種するための方法および組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10653757B2 (enExample) |
| EP (1) | EP2734229B1 (enExample) |
| JP (1) | JP2014521605A (enExample) |
| CN (1) | CN103998056B (enExample) |
| AU (1) | AU2012287513A1 (enExample) |
| BR (1) | BR112014001409A2 (enExample) |
| CA (1) | CA2842626A1 (enExample) |
| EA (1) | EA035513B1 (enExample) |
| ES (1) | ES2716800T3 (enExample) |
| GE (1) | GEP201706766B (enExample) |
| UA (1) | UA114286C2 (enExample) |
| WO (1) | WO2013015831A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070077256A1 (en) | 1999-11-19 | 2007-04-05 | Los Angeles Biomedical Research Institute | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| WO2013015831A1 (en) | 2011-07-22 | 2013-01-31 | Novadigm Therapeutics, Inc. | Methods and compositions for vaccinating against staphylococcus aureus |
| HK1220389A1 (zh) * | 2013-03-14 | 2017-05-05 | Wang Rongfu | 调控调节性t细胞功能的方法和组合物 |
| US11198724B2 (en) | 2013-03-14 | 2021-12-14 | The Regents Of The University Of Michigan | Treatment of staphylococcal disorders |
| AU2014227748B2 (en) * | 2013-03-15 | 2019-02-14 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Compositions and methods for treating fungal and bacterial pathogens |
| WO2017155949A1 (en) | 2016-03-09 | 2017-09-14 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Methods and kits for use in preventing and treating vulvovaginal candidiasis |
| CN105713096B (zh) * | 2016-03-29 | 2019-01-01 | 黑龙江八一农垦大学 | 一种预防金黄色葡萄球菌感染的att融合蛋白的制备及应用 |
| CA3084954A1 (en) | 2017-12-05 | 2019-06-13 | BioPlx, Inc. | Methods and compositions to prevent microbial infection |
| CN112203684A (zh) * | 2018-04-10 | 2021-01-08 | 海港医学中心洛杉矶生物医学研究所 | 耳念珠菌感染的治疗方法 |
| CN112940987B (zh) * | 2021-04-10 | 2022-10-14 | 福建省农业科学院畜牧兽医研究所 | 一株兔金黄色葡萄球菌及其在制备灭活疫苗中的应用 |
| US20220354935A1 (en) * | 2021-04-21 | 2022-11-10 | Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center | Vaccination against fungal epitopes to prevent inflammatory bowel diseases |
| WO2025032534A2 (en) * | 2023-08-09 | 2025-02-13 | Glaxosmithkline Biologicals Sa | Modified proteins |
| WO2025240443A1 (en) * | 2024-05-14 | 2025-11-20 | University Of Rochester | Candida for use in prevention or mitigation of cutaneous viral infections |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1133829A (en) | 1978-08-24 | 1982-10-19 | National Research Development Corporation | Pasteurellosis vaccines |
| US5622939A (en) | 1992-08-21 | 1997-04-22 | Alpha-Beta Technology, Inc. | Glucan preparation |
| WO1993024640A2 (en) | 1992-06-04 | 1993-12-09 | The Regents Of The University Of California | Methods and compositions for in vivo gene therapy |
| EP0702516A4 (en) | 1993-06-01 | 1998-04-22 | Life Technologies Inc | GENETIC IMMUNIZATION WITH CATIONIC LIPIDS |
| US5961970A (en) | 1993-10-29 | 1999-10-05 | Pharmos Corporation | Submicron emulsions as vaccine adjuvants |
| AU2657495A (en) | 1994-05-23 | 1995-12-18 | Research And Development Institute, Inc. | Candida albicans adhesin as a vaccine |
| US5668263A (en) | 1994-12-16 | 1997-09-16 | Smithkline Beecham Corporation | Conserved yeast nucleic acid sequences |
| ATE200029T1 (de) | 1995-06-07 | 2001-04-15 | Pfizer | In ovo impfung gegen coccidiose |
| CA2255669A1 (en) | 1996-05-16 | 1997-11-20 | The Texas A & M University System | Collagen binding protein compositions and methods of use |
| US6747137B1 (en) | 1998-02-13 | 2004-06-08 | Genome Therapeutics Corporation | Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics |
| US6248329B1 (en) | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| US6703025B1 (en) | 1998-08-31 | 2004-03-09 | Inhibitex, Inc. | Multicomponent vaccines |
| US20060083750A1 (en) | 1999-11-19 | 2006-04-20 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis |
| US20070077256A1 (en) * | 1999-11-19 | 2007-04-05 | Los Angeles Biomedical Research Institute | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| US8541008B2 (en) * | 1999-11-19 | 2013-09-24 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Pharmaceutical compositions and methods to vaccinate against candidiasis |
| US7067138B1 (en) | 1999-11-19 | 2006-06-27 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis |
| EP3698626A1 (en) | 2001-11-30 | 2020-08-26 | Amgen Fremont Inc. | Transgenic animals bearing human ig lambda light chain genes |
| WO2003099325A1 (en) | 2002-05-21 | 2003-12-04 | Schering-Plough Ltd. | Methods for the in vitro culture of sporozoea sp. and user thereof |
| US7241613B1 (en) * | 2002-06-05 | 2007-07-10 | Oscient Pharmaceuticals Corporation | Identification of Candida cell surface proteins and their uses |
| AU2003290867A1 (en) | 2002-11-12 | 2004-06-03 | The Brigham And Women's Hospital, Inc. | Methods and products for treating staphylococcal infections |
| CN1882360A (zh) * | 2003-11-21 | 2006-12-20 | 辉瑞产品公司 | 抗生素作为疫苗佐剂的用途 |
| WO2005060713A2 (en) | 2003-12-19 | 2005-07-07 | Inhibitex, Inc. | Method of inhibiting candida-related infections using donor selected or donor stimulated immunoglobulin compositions |
| GB0420466D0 (en) | 2004-09-14 | 2004-10-20 | Cassone Antonio | Anti-glucan antibodies |
| WO2006036817A2 (en) | 2004-09-24 | 2006-04-06 | Microbia, Inc. | Fungal variants and uses thereof |
| CA2489194A1 (en) | 2004-12-03 | 2006-06-03 | Guilhem Janbon | Polypeptides involved in candida biofilm formation and uses thereof |
| WO2007126813A2 (en) | 2006-03-29 | 2007-11-08 | Inhibitex, Inc. | Cross-reactive monoclonal antibodies recognizing als family proteins |
| KR20080110908A (ko) | 2006-04-17 | 2008-12-19 | 쉐링-프라우 리미티드 | 재조합의 약독화된 클로스트리듐 유기체 및 백신 |
| EP2164511A1 (en) | 2007-05-22 | 2010-03-24 | Baylor College Of Medicine | Immune complex vaccination as a strategy to enhance immunity in the elderly and other immune compromised populations |
| EP2039764A1 (en) * | 2007-09-19 | 2009-03-25 | Pevion Biotech AG | Truncated secretory aspartyl proteinase 2 |
| WO2009148895A1 (en) | 2008-05-29 | 2009-12-10 | Intervet International B.V. | Coccidiosis vaccines |
| US20100150942A1 (en) | 2008-12-03 | 2010-06-17 | Cantor Thomas L | Affinity purified human polyclonal antibodies and methods of making and using them |
| CN102481352A (zh) * | 2009-06-22 | 2012-05-30 | 惠氏有限责任公司 | 金黄色葡萄球菌抗原的免疫原性组合物 |
| RU2015122387A (ru) | 2009-07-03 | 2015-10-27 | Лос-Анжелес Биомедикал Ресёрч Институт Эт Харбор-Укла Медикал Центер | Hyr1 в качестве мишени для активной и пассивной иммунизации против candida |
| WO2012163533A1 (en) | 2011-06-01 | 2012-12-06 | Eth Zurich | T cell epitope of candida albicans |
| WO2013015831A1 (en) | 2011-07-22 | 2013-01-31 | Novadigm Therapeutics, Inc. | Methods and compositions for vaccinating against staphylococcus aureus |
| GB201503812D0 (en) | 2015-03-06 | 2015-04-22 | Univ Aberdeen | Antibody molecules and uses thereof |
| WO2017155949A1 (en) | 2016-03-09 | 2017-09-14 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Methods and kits for use in preventing and treating vulvovaginal candidiasis |
-
2012
- 2012-07-20 WO PCT/US2012/000328 patent/WO2013015831A1/en not_active Ceased
- 2012-07-20 US US14/234,269 patent/US10653757B2/en active Active
- 2012-07-20 BR BR112014001409A patent/BR112014001409A2/pt not_active IP Right Cessation
- 2012-07-20 ES ES12817530T patent/ES2716800T3/es active Active
- 2012-07-20 EA EA201391200A patent/EA035513B1/ru not_active IP Right Cessation
- 2012-07-20 AU AU2012287513A patent/AU2012287513A1/en not_active Abandoned
- 2012-07-20 EP EP12817530.4A patent/EP2734229B1/en not_active Not-in-force
- 2012-07-20 UA UAA201310981A patent/UA114286C2/uk unknown
- 2012-07-20 CN CN201280046321.4A patent/CN103998056B/zh not_active Expired - Fee Related
- 2012-07-20 CA CA2842626A patent/CA2842626A1/en active Pending
- 2012-07-20 GE GEAP201213225A patent/GEP201706766B/en unknown
- 2012-07-20 JP JP2014521610A patent/JP2014521605A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8980275B2 (en) | Targeted heterologous antigen presentation on calicivirus virus-like particles | |
| MX2023000411A (es) | Vacuna combinada de sars-cov-2 e influenza. | |
| JP2012523246A5 (enExample) | ||
| JP2015214545A5 (enExample) | ||
| JP2014534202A5 (enExample) | ||
| JP2011250797A5 (enExample) | ||
| JP2016539946A5 (enExample) | ||
| NZ612315A (en) | Compositions for immunising against staphylococcus aureus | |
| IL276210B2 (en) | Mers-cov vaccine | |
| JP2009539965A5 (enExample) | ||
| ES2642892T3 (es) | Protección de vacuna multivalente contra la infección por estafilococo aureus | |
| GEP201706766B (en) | Methods and compositions for vaccinating against staphylococcus aureus | |
| JP2015529677A5 (enExample) | ||
| JP2014519817A5 (enExample) | ||
| JP5661744B2 (ja) | 腸球菌由来のポリペプチド、及びワクチン接種のためのその使用 | |
| WO2011112906A3 (en) | Novel immunogens and methods for discovery and screening thereof | |
| KR20150020164A (ko) | 보강제 제형 및 방법 | |
| CN102000330B (zh) | 一种核酸疫苗佐剂及其构建方法 | |
| CA2795308A1 (en) | Parapoxvirus expressing the vp60 major capsid protein of the rabbit haemorrhagic disease virus | |
| CO6300795A2 (es) | Un vector adenovirico de simio para uso en una vacuna | |
| KR20180080178A (ko) | 세균성 백신 및 바이러스성 백신 방법 | |
| CN102038951B (zh) | 基于mcp-1设计的核酸疫苗佐剂及其构建方法 | |
| NZ591738A (en) | Non-typhoidal salmonella vaccines comprising a polypeptide which is an outer membrane protein d of non typoidal salmonella | |
| GB2599572A (en) | Compositions and methods of manufacturing trivalent filovirus vaccines | |
| US9233150B2 (en) | Combination vaccine |